Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00783
|
|||||
| Drug Name |
Ciprofloxacin
|
|||||
| Synonyms |
85721-33-1; BAY q 3939; Bacquinor; Baflox; Bernoflox; Cifloxin; Cilab; Ciplus; Ciprecu; Ciprinol; Cipro IV; Cipro XR; Ciprobay; Ciprocinol; Ciprodar; Ciproflox; Ciprofloxacin Hydrochloride; Ciprofloxacin intratympanic - Otonomy; Ciprofloxacina; Ciprofloxacine; Ciprofloxacino; Ciprofloxacinum; Ciprogis; Ciprolin; Ciprolon; Cipromycin; Ciproquinol; Ciprowin; Ciproxan; Ciproxina; Ciproxine; Ciriax; Citopcin; Cixan; Corsacin; Cycin; Fimoflox; GW1843; Ipiflox; Italnik; Loxan; Probiox; Proflaxin; Quinolid; Quintor; Rancif; Roxytal; Septicide; Spitacin; Superocin; Unex; Zumaflox; ciprofloxacin
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Seizure [ICD11: 8A68] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H18FN3O3
|
|||||
| Canonical SMILES |
C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
|
|||||
| InChI |
InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)
|
|||||
| InChIKey |
MYSWGUAQZAJSOK-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 85721-33-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 331.34 | Topological Polar Surface Area | 72.9 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 3 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
-1.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:100241
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BCRP | Transporter Info | Breast cancer resistance protein | Substrate | [2] | |
| MRP4 | Transporter Info | Multidrug resistance-associated protein 4 | Substrate | [3] | ||
| OAT3 | Transporter Info | Organic anion transporter 3 | Substrate | [4] | ||
| OATP1A2 | Transporter Info | Organic anion transporting polypeptide 1A2 | Substrate | [5] | ||
| References | ||||||
| 1 | Ciprofloxacin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Fluoroquinolone efflux mediated by ABC transporters. J Pharm Sci. 2008 Sep;97(9):3483-93. | |||||
| 3 | Identification of the efflux transporter of the fluoroquinolone antibiotic ciprofloxacin in murine macrophages: studies with ciprofloxacin-resistant cells. Antimicrob Agents Chemother. 2009 Jun;53(6):2410-6. | |||||
| 4 | Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Mol Pharmacol. 2008 Jul;74(1):122-31. | |||||
| 5 | Fruit juice inhibition of uptake transport: a new type of food-drug interaction. Br J Clin Pharmacol. 2010 Nov;70(5):645-55. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.